Evidence map›Paper›PMID 42599737›Full record

ReviewAmerican journal of reproductive immunology (New York, N.Y. : 1989)2026

Is the HLA System Really Involved in Implantation, Pregnancy, or Abortion of the Fetus?: Strengths, Weaknesses, and Controversial Points.

Alicia Hita, Carmen Botella, José Antonio Galian, Rosana González-López, Marina Fernández-González, María José Alegría-Marcos, Rosa Moya-Quiles, Helios Martínez-Banaclocha, Manuel Muro-Pérez, Javier Muro and 3 more

Abstract readReview
In one paragraph

Review in American journal of reproductive immunology (New York, N.Y. : 1989), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alicia HitaImmunology Service, University Clinical Hospital Virgen de La Arrixaca, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
Carmen BotellaImmunology Service, University Clinical Hospital Virgen de La Arrixaca, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.ORCID https://orcid.org/0000-0002-6839-0856
José Antonio GalianImmunology Service, University Clinical Hospital Virgen de La Arrixaca, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
Rosana González-LópezImmunology Service, University Clinical Hospital Virgen de La Arrixaca, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
Marina Fernández-GonzálezImmunology Service, University Clinical Hospital Virgen de La Arrixaca, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
María José Alegría-MarcosImmunology Service, University Clinical Hospital Virgen de La Arrixaca, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
Rosa Moya-QuilesImmunology Service, University Clinical Hospital Virgen de La Arrixaca, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.ORCID https://orcid.org/0000-0003-3677-6372
Helios Martínez-BanaclochaImmunology Service, University Clinical Hospital Virgen de La Arrixaca, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
Manuel Muro-PérezImmunology Service, University Clinical Hospital Virgen de La Arrixaca, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
Javier MuroImmunology Service, University Clinical Hospital Virgen de La Arrixaca, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
Alfredo MinguelaImmunology Service, University Clinical Hospital Virgen de La Arrixaca, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.ORCID https://orcid.org/0000-0003-2472-5893
Isabel LegazDepartment of Legal and Forensic Medicine, Biomedical Research Institute of Murcia (IMIB), Faculty of Medicine, University of Murcia, Murcia, Spain.ORCID https://orcid.org/0000-0002-1140-4313
Manuel MuroImmunology Service, University Clinical Hospital Virgen de La Arrixaca, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.ORCID https://orcid.org/0000-0001-9987-0994

Funding

Biomedical Research Institute of MurciaVirgen de la Arrixaca University Clinic Hospital
6 · The paper itself

Abstract

problemsPregnancy is a sensitizing event for human leukocyte antigen (HLA) alleles, as the fetus, acting as a semi-allograft, expresses maternal and paternal haplotypes in a codominant manner. Consequently, the mother may develop anti-HLA antibodies directed against the paternal haplotype. However, unlike in organ transplantation, this sensitization is not usually associated with fetal rejection in multiparous women, raising a central question in reproductive immunology: How is maternal-fetal tolerance achieved and maintained? METHOD OF STUDY: This review examines the influence of the HLA system on the immunological mechanisms underlying maternal-fetal tolerance.

resultsAccumulating evidence suggests that this phenomenon results from a complex network of cellular and molecular interactions. The roles of non-classical HLA molecules, particularly HLA-G, the modulation of NK activity via KIR receptors, and the expansion of regulatory T cells, which contribute to the maintenance of systemic immunological tolerance, are highlighted. In parallel, the relevance of anti-HLA antibodies and polymorphisms in HLA regulatory regions in susceptibility to gestational complications has been investigated.

conclusionIt considers how insights from reproductive immunology may inform related fields such as transplantation and oncology.

Indexed as

Abortion, SpontaneousEmbryo ImplantationFetusHLA AntigensKiller Cells, NaturalT-Lymphocytes, RegulatoryAnimalsFemaleHistocompatibility, Maternal-FetalHLA-G AntigensHumansImmune TolerancePregnancyReceptors, KIRHLA AntigensHLA-G AntigensReceptors, KIRallorecognitionantipaternal antibodiesHLA‐GHLA moleculeshuman leukocyte antigen antibodiesimmune tolerancepregnancypregnancy complications

Identifiers

PMID42599737
PMCPMC13475587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.